The SEC charges an FDA chemist with insider trading on confidential information about...

|By:, SA News Editor

The SEC charges an FDA chemist with insider trading on confidential information about announcements of FDA drug approval decisions. The chemist traded in advance of at least 27 public announcements about FDA drug approval decisions involving 19 publicly traded companies, the SEC alleges.